Jordan Schaefer retweeted
#EHR does a reasonably good job at identifying aspirin use in patients without a history of cardiovascular disease. Efforts to improve medication reconciliation, including OTC meds, would improve accuracy and reliability. ja.ma/4593N37
Jordan Schaefer retweeted
Webinar Recording Now Available!
Aspirin De-Prescribing and PPI Prescribing: Gastroprotection Among Patients Taking Oral Anticoagulants
Presenters: Jacob Kurlander, MD, MS & Jordan Schaefer, MD, FACP
Watch Now: buff.ly/3z197XO
Jordan Schaefer retweeted
Recurrent thrombosis and MGUS? Great story on how we diagnosed our patient with a new #thrombophilia #MGTS Monoclonal gammopathy of thrombotic significance with colleague @JordanKSchaefer @mayocliniclabs @MayoClinicPath @MayoClinic discoverysedge.mayo.edu/2023…
Jordan Schaefer retweeted
Excited about our @BloodJournal paper on a new thrombophilia: #MGTS characterized by thrombosis due to MONOCLONAL anti-PF4 antibodies. Congrats to colleagues from multiple institutions for this breakthrough finding!! @mayocliniclabs @MayoClinic @umichCVC ashpublications.org/blood/ar…
Jordan Schaefer retweeted
An anticoagulation clinic–based #aspirin deimplementation intervention was associated with improved guideline-concordant aspirin use and fewer bleeding complications. ja.ma/3qUut5i #Research
Jordan Schaefer retweeted
Today, we proudly announce the 36 recipients of our 2022 ASH Scholar Awards, one of our most prestigious research award programs for fellows & junior faculty dedicating a #career to #hematology research! 🎉🩸 #ASHAwards
Read about our awardees today: loom.ly/B_gVBVs
Jordan Schaefer retweeted
Jordan Schaefer compared DOAC+aspirin vs Warfarin+aspirin for AF or VTE. Not RCT. No differences in thrombosis or bleeding, except perhaps a higher bleeding risk for Rivaroxaban. #ASH21
Jordan Schaefer retweeted
Proud to co-author this paper with Dr Jordan Schaefer at @UMich for @JNCCN. Hope it is helpful in determining which AC to use.
@huntsmancancer @UtahHemeOnc
How to Choose An Appropriate Anticoagulant for Cancer-Associated Thrombosis
jnccn.org/view/journals/jncc…
Jordan Schaefer retweeted
✅ out our 📝 & response to our 🙋🏻♀️🙋🏽♂️ to⤵️
jamanetwork.com/journals/jam…
🙏🏼 @JordanKSchaefer @GBarnesMD
💌To Deprescribe or Not to Deprescribe Aspirin💌
team #droptheASA ❣️
ja.ma/3Dzzc1x via @JAMAInternalMed part of @JAMANetwork
@amanmadh @PlateletDoc jamanetwork.com/journals/jam…
Jordan Schaefer retweeted
When 1+1=-1: People taking both DOACs and low-dose aspirin had significantly higher bleeding rates than those taking a DOAC alone: 31.6 bleeds vs. 26.0 bleeds per 100 patient-years.
Jordan Schaefer retweeted
#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events dlvr.it/RycBjp #StudyGraphics #aspirin
Jordan Schaefer retweeted
Combined #DOAC plus #aspirin when there isn't a strong indication is associated with higher rates of non-major bleeding. Similar findings with warfarin use. Important findings from @MAQI_2 in @JAMAInternalMed jamanetwork.com/journals/jam…
Jordan Schaefer retweeted
New article: Venous #thrombosis is leading cause of death in #cancer Low molecular weight heparin & direct oral anticoagulants used to treat cancer associated thrombosis. Schaefer, @MarcCarrier1 et al @UMich find pts remain on DOACs longer.
bit.ly/2VztDvl
Jordan Schaefer retweeted
Come visit our booth (#2309) at the 61st ASH Annual Meeting @ASH_hematology to learn about our free anticoagulation resources. #ASH19 #MAQI2 #anticoagulation
Jordan Schaefer retweeted
NEW in @JAMAInternalMed, @GBarnesMD and team found more than 1/3 of patients risked major bleeding by doubling up on blood thinners:
jamanetwork.com/journals/jam…
